trazodone has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trazodone was associated with lower side effects and with augmentation treatments." | 1.91 | Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting. ( De Ronchi, D; Fabbri, C; Ferentinos, P; Kasper, S; Mendlewicz, J; Montgomery, S; Panariello, F; Rujescu, D; Serretti, A; Souery, D; Zohar, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panariello, F | 1 |
| Kasper, S | 1 |
| Zohar, J | 1 |
| Souery, D | 1 |
| Montgomery, S | 1 |
| Ferentinos, P | 1 |
| Rujescu, D | 1 |
| Mendlewicz, J | 1 |
| De Ronchi, D | 1 |
| Serretti, A | 1 |
| Fabbri, C | 1 |
1 other study available for trazodone and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting.
Topics: Anxiety Disorders; Depression; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects a | 2023 |